Australia markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
26.00+0.07 (+0.27%)
At close: 04:00PM EST
25.48 -0.52 (-2.00%)
After hours: 05:15PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
304,959
280,259
161,855
103,303
50,294
Selling general and administrative
93,747
87,589
58,243
45,813
33,169
Total operating expenses
398,706
367,848
220,098
149,116
83,463
Operating income or loss
-398,706
-367,848
-220,098
-149,116
-83,463
Total other income/expenses net
-19,786
6,878
-5,393
-3,274
-46,433
Income before tax
-396,215
-351,351
-225,334
-152,166
-128,344
Income tax expense
352
160
0
-24
45
Income from continuing operations
-396,567
-351,511
-225,334
-152,142
-128,389
Net income
-396,567
-351,511
-225,334
-152,142
-128,389
Net income available to common shareholders
-396,567
-351,511
-225,334
-152,142
-128,389
Basic EPS
-2.50
-2.32
-1.65
-2.01
-1.01
Diluted EPS
-2.50
-2.32
-1.65
-2.01
-1.01
Basic average shares
156,909
151,266
136,577
73,643
127,124
Diluted average shares
156,909
151,266
136,577
73,643
127,124